These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31148425)

  • 1. [Challenges in managing diabetes in chronic hemodialysis].
    Lamine F; Chtioui H; Schwotzer N; Pruijm M; Nobre D; Phan O; Ammor N; Andrey M; Grangier-Bernard P; Zanchi A
    Rev Med Suisse; 2019 May; 15(653):1132-1139. PubMed ID: 31148425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
    Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
    Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hemodialysis-associated hypoglycemia in patients with type 2 diabetes using a continuous glucose monitoring system.
    Jung HS; Kim HI; Kim MJ; Yoon JW; Ahn HY; Cho YM; Oh KH; Joo KW; Lee JG; Kim SY; Park KS
    Diabetes Technol Ther; 2010 Oct; 12(10):801-7. PubMed ID: 20809681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
    Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
    J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control and vascular diseases under oral antidiabetic drug versus insulin therapy and/or diet alone during the first year of hemodialysis in type 2 diabetic patients with ESRD.
    Biesenbach G; Bodlaj G; Ebner S; Biesenbach P; Pieringer H
    Int Urol Nephrol; 2011 Dec; 43(4):1155-60. PubMed ID: 20640938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycemic control in patients with diabetes mellitus on hemodialysis].
    Lobanova KG; Severina AS; Martinov SA; Shamkhalova MS; Shestakova MV
    Ter Arkh; 2019 Oct; 91(10):124-134. PubMed ID: 32598642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
    Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
    Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia.
    Hayashi A; Shimizu N; Suzuki A; Matoba K; Momozono A; Masaki T; Ogawa A; Moriguchi I; Takano K; Kobayashi N; Shichiri M
    Diabetes Care; 2021 Jul; 44(7):1647-1656. PubMed ID: 34045240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic pattern in diabetic patients on hemodialysis: continuous glucose monitoring (CGM) analysis.
    Gai M; Merlo I; Dellepiane S; Cantaluppi V; Leonardi G; Fop F; Guarena C; Grassi G; Biancone L
    Blood Purif; 2014; 38(1):68-73. PubMed ID: 25300368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
    Ling J; Ng JKC; Chan JCN; Chow E
    Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus.
    Derosa G; Libetta C; Esposito P; Borettaz I; Tinelli C; D'Angelo A; Maffioli P
    J Diabetes Complications; 2015; 29(8):1136-41. PubMed ID: 26387810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing diabetes in hemodialysis patients: observations and recommendations.
    Shrishrimal K; Hart P; Michota F
    Cleve Clin J Med; 2009 Nov; 76(11):649-55. PubMed ID: 19884294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
    Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia in diabetic patients undergoing chronic hemodialysis.
    Sun CY; Lee CC; Wu MS
    Ther Apher Dial; 2009 Apr; 13(2):95-102. PubMed ID: 19379147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?
    Ichikawa H; Nagake Y; Takahashi M; Nakazono H; Kawabata K; Shikata K; Makino H
    Nihon Jinzo Gakkai Shi; 1996 Jul; 38(7):305-8. PubMed ID: 8741392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.